|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| Apr. 30 | Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 27 | Jolt Health Inc. announced that it has received CAD 0.5 million in funding | CI |
Love Pharma Inc. (CNSX:LUV) signed a non-binding Letter of Intent to acquire Naltrexone Therapeutics Inc. for CAD 2 million on October 10, 2022. 100% of company will be purchased and become a wholly owned subsidiary. The company anticipates closing the transaction within 30 days.
The transaction is subject to final due diligence, further details will be released upon the signing of a definitive agreement.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 466K | |
| +31.84% | 588B | |
| -3.42% | 364B | |
| +18.02% | 326B | |
| +4.27% | 285B | |
| +15.28% | 239B | |
| +9.96% | 210B | |
| -7.03% | 200B | |
| +8.12% | 167B | |
| -1.42% | 161B |
JOLT HEALTH INC. 
